Most toddlers born with otoferlin deafness get cochlear implants in infancy and they are thus ineligible with the trial. The implants somewhat change the cochlea, which could hamper the interpretation of gene therapy success. Aissam’s demo is among 5 that are possibly underway (the Other people are in China https://artsuppliesonline.us/products/japanese-sakura-chiyo-origami-paper-kit